Endothelial Unfolded Protein Response‐Mediated Cytoskeletal Effects DOI
Joy T. Folahan,

Saikat Fakir,

Nektarios Barabutis

и другие.

Cell Biochemistry and Function, Год журнала: 2024, Номер 42(8)

Опубликована: Окт. 25, 2024

ABSTRACT The endothelial semipermeable monolayers ensure tissue homeostasis, are subjected to a plethora of stimuli, and their function depends on cytoskeletal integrity remodeling. permeability those membranes can fluctuate maintain organ homeostasis. In cases severe injury, inflammation or disease, barrier hyperpermeability cause irreparable damage endothelium‐dependent issues, eventually death. Elucidation the signaling regulating structure promotes development targeted pharmacotherapies towards disorders related impaired endothelium (e.g., acute respiratory distress syndrome, sepsis). Recent reports investigate role unfolded protein response in function. Herein we review components, function; interrelations health disorder. Moreover, emphasize modulators, since they ameliorate illness leak.

Язык: Английский

Exposure to different surface-modified polystyrene nanoparticles caused anxiety, depression, and social deficit in mice via damaging mitochondria in neurons DOI
Yuhan Ma, Dihui Xu,

Zicheng Wan

и другие.

The Science of The Total Environment, Год журнала: 2024, Номер 919, С. 170739 - 170739

Опубликована: Фев. 9, 2024

Язык: Английский

Процитировано

25

Insights into epileptogenesis from post-traumatic epilepsy DOI
Matthew Pease, Kunal Gupta, Solomon L. Moshé

и другие.

Nature Reviews Neurology, Год журнала: 2024, Номер 20(5), С. 298 - 312

Опубликована: Апрель 3, 2024

Язык: Английский

Процитировано

22

Advancing neurological disorders therapies: Organic nanoparticles as a key to blood-brain barrier penetration DOI Creative Commons
Zahra Razavi,

Seyed Sina Alizadeh,

F. S. Razavi

и другие.

International Journal of Pharmaceutics, Год журнала: 2025, Номер 670, С. 125186 - 125186

Опубликована: Янв. 8, 2025

The blood-brain barrier (BBB) plays a vital role in protecting the central nervous system (CNS) by preventing entry of harmful pathogens from bloodstream. However, this also presents significant obstacle when it comes to delivering drugs for treatment neurodegenerative diseases and brain cancer. Recent breakthroughs nanotechnology have paved way creation wide range nanoparticles (NPs) that can serve as carriers diagnosis therapy. Regarding their promising properties, organic NPs potential be used effective drug delivery across BBB based on recent advancements. These remarkable ability penetrate using various mechanisms. This review offers comprehensive examination intricate structure distinct properties BBB, emphasizing its crucial function preserving balance regulating transport ions molecules. disruption conditions such stroke, Alzheimer's disease, Parkinson's disease highlights importance developing creative approaches drugs. Through encapsulation therapeutic molecules precise targeting processes vasculature, NP formulations present hopeful strategy improve BBB. We explore changes pathological investigate factors affect successful into brain. In addition, we most systems associated with shown positive results treating ischemic disorders. opens up new possibilities nanotechnology-based therapies cerebral diseases.

Язык: Английский

Процитировано

12

Neurotoxicity of ochratoxin A: Molecular mechanisms and neurotherapeutic strategies DOI

Blessing A. Obafemi,

Isaac A. Adedara, João Batista Teixeira da Rocha

и другие.

Toxicology, Год журнала: 2023, Номер 497-498, С. 153630 - 153630

Опубликована: Сен. 13, 2023

Язык: Английский

Процитировано

26

Cellular junction dynamics and Alzheimer’s disease: a comprehensive review DOI
Keyvan Asghari, Zahra Niknam,

Shadi Mohammadpour-Asl

и другие.

Molecular Biology Reports, Год журнала: 2024, Номер 51(1)

Опубликована: Фев. 1, 2024

Язык: Английский

Процитировано

10

Dysregulation of neural tube vascular development as an aetiological factor in autism spectrum disorder: Insights from valproic acid exposure DOI Open Access
Jorge Manzo, Marı́a Elena Hernández, María Rebeca Toledo‐Cárdenas

и другие.

The Journal of Physiology, Год журнала: 2025, Номер unknown

Опубликована: Янв. 2, 2025

Abstract Autism spectrum disorder (ASD) is a prevalent neurodevelopmental condition affecting substantial number of children globally, characterized by diverse aetiologies, including genetic and environmental factors. Emerging research suggests that neurovascular dysregulation during development could significantly contribute to autism. This review synthesizes the potential role vascular abnormalities in pathogenesis ASD explores insights from studies on valproic acid (VPA) exposure neural tube development. VPA, widely used antiepileptic drug mood stabilizer, crosses placental barrier impacts developing fetal brain. Studies indicate VPA disrupts normal angiogenesis reducing expression levels endothelial growth factor A (VEGFA) its receptors, purinergic signalling, which are crucial for both Such disruptions may lead neuronal migration pathfinding, potentially contributing behavioural manifestations ASD. Thus despite relatively limited findings, improper vascularization appears be ASD, as also suggested studies. Integrating these insights, it hypothesized factors should considered aetiological analysis idiopathic image

Язык: Английский

Процитировано

2

Brain delivery of fibronectin through bioactive phosphorous dendrimers for Parkinson's disease treatment via cooperative modulation of microglia DOI Creative Commons

Waicong Dai,

Mengsi Zhan, Yue Gao

и другие.

Bioactive Materials, Год журнала: 2024, Номер 38, С. 45 - 54

Опубликована: Апрель 23, 2024

Effective treatment of Parkinson's disease (PD), a prevalent central neurodegenerative disorder particularly affecting the elderly population, still remains huge challenge. We present here novel nanomedicine formulation based on bioactive hydroxyl-terminated phosphorous dendrimers (termed as AK123) complexed with fibronectin (FN) anti-inflammatory and antioxidative activities. The created optimized AK123/FN nanocomplexes (NCs) size 223 nm display good colloidal stability in aqueous solution can be specifically taken up by microglia through FN-mediated targeting. show that NCs are able to consume excessive reactive oxygen species, promote M2 polarization inhibit nuclear factor-kappa B signaling pathway downregulate inflammatory factors. With abundant dendrimer surface hydroxyl terminal groups, developed cross blood-brain barrier (BBB) exert targeted therapy PD mouse model AK123-mediated anti-inflammation for antioxidant effects, thus reducing aggregation α-synuclein restoring contents dopamine tyrosine hydroxylase normal levels vivo. dendrimer/FN combine advantages BBB-crossing per se phosphorus FN, which is expected extended different diseases.

Язык: Английский

Процитировано

9

SARS‐CoV‐2 induces blood‐brain barrier and choroid plexus barrier impairments and vascular inflammation in mice DOI

Haowen Qiao,

Xiangxue Deng,

Lingxi Qiu

и другие.

Journal of Medical Virology, Год журнала: 2024, Номер 96(5)

Опубликована: Май 1, 2024

Abstract The coronavirus disease of 2019 (COVID‐19) pandemic has led to more than 700 million confirmed cases and nearly 7 deaths. Although severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) virus mainly infects the system, neurological complications are widely reported in both infection long‐COVID cases. Despite success vaccines antiviral treatments, neuroinvasiveness SARS‐CoV‐2 remains an important question, which is also centered on mystery whether capable breaching barriers into central nervous system. By studying K18‐hACE2 model, we observed clear evidence microvascular damage breakdown blood‐brain barrier (BBB). Mechanistically, caused pericyte damage, tight junction loss, endothelial activation vascular inflammation, together drive injury BBB impairment. In addition, blood‐cerebrospinal fluid at choroid plexus was impaired after infection. Therefore, cerebrovascular dysfunctions aspects COVID‐19 may contribute acutely long COVID.

Язык: Английский

Процитировано

9

Engineered exosomes derived from stem cells: a new brain-targeted strategy DOI
Ahmed Waqas,

Songze Huang,

Lukui Chen

и другие.

Expert Opinion on Drug Delivery, Год журнала: 2024, Номер 21(1), С. 91 - 110

Опубликована: Янв. 2, 2024

Using engineered exosomes produced from stem cells is an experimental therapeutic approach for treating brain diseases. According to reports, preclinical research has demonstrated notable neurogenesis and angiogenesis effects using modified cell-derived exosomes. These biological nanoparticles have a variety of anti-apoptotic, anti-inflammatory, antioxidant properties that make them very promising nervous system disorders.

Язык: Английский

Процитировано

8

Revolutionizing Parkinson’s treatment: Harnessing the potential of intranasal nanoemulsions for targeted therapy DOI
Gulshan Sharma, Karan Wadhwa, Shobhit Kumar

и другие.

Drug Delivery and Translational Research, Год журнала: 2025, Номер unknown

Опубликована: Янв. 8, 2025

Язык: Английский

Процитировано

1